Cargando…

P11 Evaluation of in vitro activity of double β-lactam ‘therapy’ in Escherichia coli: what is the association between ‘synergy’ and in vitro susceptibility?

BACKGROUND: Emerging antimicrobial resistance is a leading cause of patient morbidity/mortality worldwide. A potential strategy in the treatment of resistant infections is the use of combination antibiotics, with the hope of achieving greater in vitro activity, including synergy. It is currently ass...

Descripción completa

Detalles Bibliográficos
Autores principales:	Suich, J, Van Der Woude, M, Wearmouth, D, Burns, P, Barlow, G
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2023
Materias:	Abstracts
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10266169/ http://dx.doi.org/10.1093/jacamr/dlad066.015

Ejemplares similares

P11 Evaluation of in vitro activity of double β-lactam therapy and relationship with PBP activity in Escherichia coli isolates
por: Suich, J, et al.
Publicado: (2022)

Outer membrane vesicles from β-lactam-resistant Escherichia coli enable the survival of β-lactam-susceptible E. coli in the presence of β-lactam antibiotics
por: Kim, Si Won, et al.
Publicado: (2018)

In vitro synergy of sertraline and tetracycline cannot be reproduced in pigs orally challenged with a tetracycline resistant Escherichia coli
por: Kromann, Sofie, et al.
Publicado: (2019)

Are envelope stress responses essential for persistence to β-lactams in Escherichia coli?
por: Rousseau, Clothilde J., et al.
Publicado: (2023)

Biofilms facilitate cheating and social exploitation of β-lactam resistance in Escherichia coli
por: Amanatidou, Elli, et al.
Publicado: (2019)

Multi-drug and β-lactam resistance in Escherichia coli and food-borne pathogens
por: Costa, M, et al.
Publicado: (2022)

Genomic Characterization of Fecal Escherichia coli Isolates with Reduced Susceptibility to Beta-Lactam Antimicrobials from Wild Hogs and Coyotes
por: Awosile, Babafela, et al.
Publicado: (2023)

Hydrogel Microparticles Functionalized with Engineered Escherichia coli as Living Lactam Biosensors
por: Ma, Conghui, et al.
Publicado: (2019)

Characterization of Beta-Lactam Resistome of Escherichia coli Causing Nosocomial Infections
por: Vázquez-López, Rosalino, et al.
Publicado: (2023)

The Lysis of Pathogenic Escherichia coli by Bacteriophages Releases Less Endotoxin Than by β-Lactams
por: Dufour, Nicolas, et al.
Publicado: (2017)

L-Form Switching in Escherichia coli as a Common β-Lactam Resistance Mechanism
por: Petrovic Fabijan, Aleksandra, et al.
Publicado: (2022)

In Vitro Selection of High-Level Beta-Lactam Resistance in Methicillin-Susceptible Staphylococcus aureus
por: Gostev, Vladimir, et al.
Publicado: (2021)

Management of clinical infections of Escherichia coli by new β-lactam/β-lactamase inhibitor combinations
por: Kadry, Ashraf Ahmed, et al.
Publicado: (2022)

Antibiotic Susceptibility Profiles and Resistance Mechanisms to β-Lactams and Polymyxins of Escherichia coli from Broilers Raised under Intensive and Extensive Production Systems
por: Ferreira, Mariana, et al.
Publicado: (2022)

In vitro reconstitution of Escherichia coli divisome activation
por: Radler, Philipp, et al.
Publicado: (2022)

Characterization and Lytic Activity of Isolated Escherichia coli Bacteriophages against Escherichia coli in vitro
por: Rahimzadeh, Golnar, et al.
Publicado: (2020)

Structural insight into YcbB-mediated beta-lactam resistance in Escherichia coli
por: Caveney, Nathanael A., et al.
Publicado: (2019)

Extraintestinal Pathogenic Escherichia coli: Beta-Lactam Antibiotic and Heavy Metal Resistance
por: Longhi, Catia, et al.
Publicado: (2022)

Antimicrobial Resistance Profiles of Adherent Invasive Escherichia coli Show Increased Resistance to β-Lactams
por: Martinez-Medina, Margarita, et al.
Publicado: (2020)

Stochastic establishment of β-lactam-resistant Escherichia coli mutants reveals conditions for collective resistance
por: Saebelfeld, Manja, et al.
Publicado: (2022)

613. Suppression of Daptomycin Resistance Development in Staphylococcus aureus Is a Class Effect of β-Lactams and Is Independent of Daptomycin–β Lactam Synergy
por: Miller, Christopher R, et al.
Publicado: (2019)

1299. In Vitro-In Vivo Discordance with β-lactams against Metallo-β-lactamase-Producing Enterobacterales: Implications for Susceptibility Testing
por: Abdelraouf, Kamilia, et al.
Publicado: (2020)

Current status of β-lactam antibiotic use and characterization of β-lactam-resistant Escherichia coli from commercial farms by integrated broiler chicken operations in Korea
por: Jung, Hye-Ri, et al.
Publicado: (2023)

Nitrofuran Derivatives Cross-Resistance Evidence—Uropathogenic Escherichia coli Nitrofurantoin and Furazidin In Vitro Susceptibility Testing
por: Bielec, Filip, et al.
Publicado: (2023)

1601. Evaluation of Synergy with β-Lactams Plus Aztreonam Against Pseudomonas aeruginosa (PSA)
por: O’Donnell, J Nicholas, et al.
Publicado: (2019)

In Vitro Synergy of Cefamandole-Tobramycin Combinations
por: Valenti, August J., et al.
Publicado: (1977)

Enterobactin-Mediated Delivery of β-Lactam Antibiotics Enhances Antibacterial Activity against Pathogenic Escherichia coli
por: Zheng, Tengfei, et al.
Publicado: (2014)

Enhancing activity of β-lactam and fluoroquinolones antibiotics by artemisinin and its derivatives against MDR Escherichia coli
por: Ul Haq, Shahbaz, et al.
Publicado: (2022)

Escherichia coli from Human Wounds: Analysis of Resistance to β-Lactams and Expression of RND Efflux Pumps
por: Rihacek, Martin, et al.
Publicado: (2023)

Mechanism of Synergy Between Tetracycline and Quercetin Against Antibiotic Resistant Escherichia coli
por: Qu, Shaoqi, et al.
Publicado: (2019)

Repurposing β-Lactams for the Treatment of Mycobacterium kansasii Infections: An In Vitro Study
por: Muñoz-Muñoz, Lara, et al.
Publicado: (2023)

Escherichia Coli: What Is and Which Are?
por: Cobo-Simón, Marta, et al.
Publicado: (2022)

Phage-Antibiotic Synergy (PAS): β-Lactam and Quinolone Antibiotics Stimulate Virulent Phage Growth
por: Comeau, André M., et al.
Publicado: (2007)

Factors essential for L,D-transpeptidase-mediated peptidoglycan cross-linking and β-lactam resistance in Escherichia coli
por: Hugonnet, Jean-Emmanuel, et al.
Publicado: (2016)

Control of Growth and Persistence of Listeria monocytogenes and β-Lactam-Resistant Escherichia coli by Thymol in Food Processing Settings
por: Cusimano, Maria Grazia, et al.
Publicado: (2020)

Comparative analysis of genetic characterization of β-lactam-resistant Escherichia coli from bulk tank milk in Korea
por: Jung, Hye-Ri, et al.
Publicado: (2021)

In vitro Susceptibility to β-Lactam Antibiotics and Viability of Neisseria gonorrhoeae Strains Producing Plasmid-Mediated Broad- and Extended-Spectrum β-Lactamases
por: Kandinov, Ilya, et al.
Publicado: (2022)

Synergy between Ursolic and Oleanolic Acids from Vitellaria paradoxa Leaf Extract and β-Lactams against Methicillin-Resistant Staphylococcus aureus: In Vitro and In Vivo Activity and Underlying Mechanisms
por: Catteau, Lucy, et al.
Publicado: (2017)

Translational frameshifting in the Escherichia coli dnaX gene in vitro.
por: Tsuchihashi, Z
Publicado: (1991)

Modification of Escherichia coli–bacteriophage interactions by surfactants and antibiotics in vitro
por: Scanlan, Pauline D., et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_ubr6ht5hmq2s5hq634v2j78dq9